Recall Z-1931-2015 ยท KNK Acid, Uric, Uricase (Colorimetric)
Roche Diagnostics Operations, Inc.
Uric Acid plus ver.2 In vitro test for the quantitative determination of uric acid in human serum, plasma and urine or Roche/Hitachi MODULAR systems, cobas c111, COBAS Integra 800 and 400 plus systems, and cobas c systems.
| Date | Jun 27, 2015 (initiated May 7, 2015) |
| Status | Terminated |
| Reason | Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine. |
| Root cause | Under Investigation by firm |
| Action | Roche Diagnostics initiated a voluntary recall and the Urgent Medical Device Correction notices were sent via UPS Ground on 05/07/2015 to customers. Customers were notified of the interference and the method sheets and package inserts will be updated with the new interference claims. The firm plans to monitor any non-responding accounts and address those customers with follow-up attempts to distribute recall notices. The firm plans to conduct level B effectiveness checks via fax and phone. Until the new method sheets are available, the Urgent Medical Device Correction serves as the updated |
| Quantity | 6255 |
| Distribution | US (nationwide) including PR. |
| FDA record | Open on fda.gov |
510(k) clearances named in this recall
| K873363 | URIC ACID PAP Boehringer Mannheim Corp., Oct 19, 1987 |